TrianglePUBLICATIONS · 8201378
Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1994 Jun
- First author
- Loehrer PJ Sr
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Loehrer PJ Sr
- type
- Author
- name
- Kim K
- type
- Author
- name
- Aisner SC
- type
- Author
- name
- Livingston R
- type
- Author
- name
- Einhorn LH
- type
- Author
- name
- Johnson D
- type
- Author
- name
- Blum R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Loehrer PJ Sr
- type
- Author
- name
- Kim K
- type
- Author
- name
- Aisner SC
- type
- Author
- name
- Livingston R
- type
- Author
- name
- Einhorn LH
- type
- Author
- name
- Johnson D
- type
- Author
- name
- Blum R
- type
- Author
- bibliography ids
- nci-bib-5ac3425c004e114622cbbbf9
- book metadata
- content sha256
- d696d20fca666148562601a7cd5b3989fc3d7b75bc998e53df390f552cc0bd0d
- document type
- citation
- dois
- 10.1200/JCO.1994.12.6.1164
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:8201378
- immutable id
- pubmed:8201378@d696d20fca666148562601a7cd5b3989fc3d7b75bc998e53df390f552cc0bd0d
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 6
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1164-8
- volume
- 12
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 8201378
- provenance
- batch id
- 83ec39f94a925b232876
- provider
- NCBI PubMed ESummary
- record sha256
- c5cd8fcd58b07afabaabd5de8a7b5b4c40ac284727c86444ed8e7f9aacd9292b
- response sha256
- 9cea37bf3451de6aa8c54c490de635080a496054249095b8c254be0e69164eca
- retrieved at
- 2026-09-09T23:45:20.996485+00:00
- publication date
- display
- 1994 Jun
- precision
- month
- year
- 1994
- publication types
- Clinical Trial
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/8201378/
- title
- Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.
Preserved source evidence · Not medical advice